mannitol has been researched along with Allergic Bronchopulmonary Mycosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, X; Moon, C; Su, Y; Watts, AB; Williams, RO | 1 |
| Amighi, K; Duret, C; Sebti, T; Vanderbist, F; Wauthoz, N | 1 |
2 other study(ies) available for mannitol and Allergic Bronchopulmonary Mycosis
| Article | Year |
|---|---|
Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
Topics: Administration, Inhalation; Aerosols; Antifungal Agents; Crystallization; Drug Compounding; Drug Design; Drug Liberation; Drug Stability; Dry Powder Inhalers; Excipients; Feasibility Studies; Humans; Invasive Pulmonary Aspergillosis; Mannitol; Particle Size; Powders; Voriconazole | 2019 |
New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Invasive Pulmonary Aspergillosis; Itraconazole; Mannitol; Microscopy, Electron, Scanning; Particle Size; Phospholipids; Powders; Solubility; Solutions; X-Ray Diffraction | 2012 |